SEC Form 4 · accession 0001144204-17-049491
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradford Barton
Officer — Chief Operating Officer
Period of report
Sep 21, 2017
Accepted (ET)
Sep 25, 2017 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 21, 2017 | F | 67,536 | $0.42 | D | 558,822 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock withheld to pay Mr. Barton's tax withholding obligations incurred in connection with the vesting of 205,715 shares of restricted stock on September 21, 2017.